Review
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jan 7, 2021; 27(1): 19-36
Published online Jan 7, 2021. doi: 10.3748/wjg.v27.i1.19
Table 1 Common characteristics and comparative features in five members of human hepatitis viruses

HAV
HBV
HCV
HDV1
HEV
Family; GenusPicornaviridae HepatovirusHepadnavirida OrthohepadnavirusFlaviviridae HepacivirusDeltaviridae DeltavirusHepeviridae Orthohepevirus
Discovery2; Frequency1983 Highest in AH1979 Highest in CH1989 Second in CH1986 Less in CH1990 Less in AH
Genome3; Length; Diameter4; Envelope5; ReceptorLinear ssRNA; 7500 nt; 27-32 nm; Quasi-envelope; UnknownCircular dsDNA; 3200 nt; 42 nm; Envelope; NTCP, HSPLinear ssRNA; 9600 nt; 55-65 nm; Envelope; CD81, SR-BICircular ssRNA; 1700 nt; 36-43 nm; Envelope; NTCP, HSPLinear ssRNA; 7200 nt; 30-34 nm; Quasi-envelope; Unknown
Incubation; Age6; Course14-30 d; Children; Acute30-180 d; Any; Acute/chronic14-180 d; Any; Acute/chronic14-160 d; Any; Acute/chronic714-70 d; Adults; Acute
Route of spreadEnteric, sexualParental, sexual, verticalParental, sexualParental, sexual, verticalEnteric, vertical, parenteral
Hepatitis diagnosisAnti-HAV IgMAnti-HBc IgM, HBs antigen, DNA by PCRAnti-HCV IgG, RNA by PCRAnti-HDV IgM, RNA by PCRAnti-HEV IgM, RNA by PCR
Vaccine; Post-exp; Av agentAvailable; Ig/vaccine; Not availableAvailable; Ig/vaccine; NA, IFN-αNot available; Not effective; DAA agentHBV vaccine; Not available; IFN-αAvailable in China; Not available; Not available
FH8; LC/HCC; Prognosis9Very rare; Nil; Full recoveryVery rare; Yes; Chronic carrierExtremely rare; Yes; High carrier rateYes; Yes; Chronic carrierYes; Nil; Full recovery